Asia (including Southeast Asia, China, and India) India – CDSCO/SEC pauses Bharat Biotech MTBVAC Phase III authorisation (6 June 2026) India’s Subject Expert Committee identified data gaps and a serious adverse...
1. RSV-B fights back: French surveillance flags notable nirsevimab escape, stressing need for smarter long-term RSV strategies This multicenter prospective cohort (POLYRES) from 32 French hospitals (Sept 2024–Apr 2025)...
One of the questions that has driven Global Health Press for years is surprisingly simple: Why do vaccination systems produce different outcomes, even when countries often share similar goals? To help answer that...
The rapidly escalating Bundibugyo Ebola outbreak in the Democratic Republic of the Congo and Uganda is more than a regional health emergency. It is another stress test of whether the world has genuinely learned anything...
When vaccination is discussed, the focus is usually on vaccines, coverage rates, disease outbreaks, or vaccine hesitancy. Yet one of the most important drivers of vaccination success often remains invisible: the...
1. Ocular Lyme Diseases This retrospective case series synthesizes 27 published reports of ocular Lyme disease between 1988 and 2025, detailing 38 patients with diverse eye manifestations. Uveitis accounted for 45% of...
Asia (Southeast Asia, China, India) India — UIP performance and adult immunization push Routine childhood coverage in India remains high, with ≥96% of children 12–23 months having received at least one vaccine; notable...
Trust is more than a public-health issue Vaccination is often evaluated through statistics such as coverage rates, disease reduction, or vaccine availability. Yet behind these numbers lies another factor that may be...